Regencell Bioscience (RGC) EBITDA (2019 - 2025)
Regencell Bioscience (RGC) EBITDA from Jun 30, 2019 to Jun 30, 2025. The TTM Regencell Bioscience (RGC) EBITDA is -$3.69M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Regencell Bioscience (RGC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -16.70% |
| 3 Years | -20.95% |
| 5 Years | +35.76% |
| All Time | +45.42% |
Annual EBITDA change of Regencell Bioscience (RGC)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$3.69M | -16.70% |
| 2024 | -$4.43M | -25.92% |
| 2023 | -$5.98M | -19.95% |
| 2022 | -$7.47M | +453.33% |
| 2021 | -$1.35M | +68.75% |
| 2020 | -$800K | +105.13% |
| 2019 | -$390K | N/A |
Comparison Regencell Bioscience (RGC) five years EBITDA CAGR with competitors
Regencell Bioscience (RGC) five years EBITDA CAGR is 35.68%.